破伤风

Brook I. Current concepts in the management of Clostridium tetani infection. Expert Rev Anti Infect Ther. 2008;6:327-336.

• 摘要

Thwaites CL, Farrar JJ. Preventing and treating tetanus. BMJ. 2003;326:117-118.

• 全文
• 摘要

World Health Organization. Tetanus vaccines: WHO position paper – February 2017. Wkly Epidemiol Rec. 2017;92:53-76.

• 全文
• 摘要

Public Health England. Tetanus: the green book, chapter 30. April 2013 [internet publication].

• 全文

Liang JL, Tiwari T, Moro P, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2018;67(No. RR-2):1–44.

• 全文
• 摘要

Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Hamborsky J, Kroger A, Wolfe S, eds. 13th ed. Washington D.C. Public Health Foundation, 2015.

• 全文

1.  Ablett JJL. Analysis and main experiences in 82 patients treated in the Leeds Tetanus Unit. In: Ellis M, ed. Symposium on tetanus in Great Britain. Boston Spa, UK: National Lending Library; 1967.

2.  Brook I. Tetanus in children. Pediatr Emerg Care. 2004;20:48-51.

• 摘要

3.  Roper MH, Vandelaer JH, Gasse FL. Maternal and neonatal tetanus. Lancet. 2007;370:1947-1959.

• 摘要

4.  Fauveau V, Mamdani M, Steinglass R, et al. Maternal tetanus: magnitude, epidemiology and potential control measures. Int J Gynaecol Obstet. 1993;40:3-12.

• 摘要

5.  Brook I. Current concepts in the management of Clostridium tetani infection. Expert Rev Anti Infect Ther. 2008;6:327-336.

• 摘要

6.  Public Health England. Immunisation against infectious disease. September 2014. https://www.gov.uk/ (last accessed 21 February 2017).

• 全文

7.  Collins S, Amirthalingam G, Beeching NJ, et al. Current epidemiology of tetanus in England, 2001-2014. Epidemiol Infect. 2016;144:3343-3353.

• 摘要

8.  Public Health England. Tetanus: information for health professionals. June 2015. https://www.gov.uk/ (last accessed 21 February 2017).

• 全文

9.  Hahne SJM, White JM, Crowcroft NS, et al. Tetanus in injecting drug users, United Kingdom. Emerg Infect Dis. 2006;12:709-710.

• 摘要

10.  Public Health England. Shooting Up: infections among people who inject drugs in the UK. November 2017 [internet publication].

• 全文

11.  Centers for Disease Control and Prevention. Tetanus. January 2017 [internet publication].

• 全文

12.  Thwaites CL, Farrar JJ. Preventing and treating tetanus. BMJ. 2003;326:117-118.

• 全文
• 摘要

13.  Kyu HH, Mumford JE, Stanaway JD, et al. Mortality from tetanus between 1990 and 2015: findings from the global burden of disease study 2015. BMC Public Health. 2017;17:179.

• 全文
• 摘要

14.  World Health Organization. Maternal and neonatal tetanus elimination (MNTE). January 2017. http://www.who.int/immunization/ (last accessed 21 February 2017).

• 全文

15.  Vandelaer J, Birmingham M, Gasse F, et al. Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative. Vaccine. 2003;21:3442-3445.

• 摘要

16.  Thwaites CL, Beeching NJ, Newton CR. Maternal and neonatal tetanus. Lancet. 2015;385:362-370.

• 摘要

17.  Demicheli V, Barale A, Rivetti A. Vaccines for women for preventing neonatal tetanus. Cochrane Database Syst Rev. 2015;(7):CD002959.

• 全文
• 摘要

18.  Farrar JJ, Yen LM, Cook T, et al. Tetanus. J Neurol Neurosurg Psychiatry. 2000;69:292-301.

• 全文
• 摘要

19.  Schiavo G, Benfenati F, Poulain B, et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. 1992;359:832-835.

• 摘要

20.  Reid PM, Brown D, Coni N, et al. Tetanus immunisation in the elderly population. J Accid Emerg Med. 1996;13:184-185.

• 全文
• 摘要

21.  Yen LM, Dao LM, Day NP, et al. Role of quinine in the high mortality of intramuscular injection tetanus. Lancet. 1994;344:786-787.

• 摘要

22.  Udwadia FE. Tetanus. New York, NY: Oxford University Press; 1994.

23.  World Health Organization. Tetanus vaccines: WHO position paper – February 2017. Wkly Epidemiol Rec. 2017;92:53-76.

• 全文
• 摘要

24.  Public Health England. Tetanus: the green book, chapter 30. April 2013 [internet publication].

• 全文

25.  Public Health England. Advice on tetanus for people who inject drugs. May 2013. http://www.gov.uk (last accessed 24 April 2015).

• 全文

26.  Blencowe H, Lawn J, Vandelaer J, et al. Tetanus toxoid immunization to reduce mortality from neonatal tetanus. Int J Epidemiol. 2010;39(suppl 1):i102-i109.


• 全文
• 摘要

27.  Committee on Obstetric Practice, Immunization and Emerging Infections Expert Work Group. Committee Opinion No. 718: Update on Immunization and Pregnancy: Tetanus, Diphtheria, and Pertussis Vaccination. Obstet Gynecol. 2017 Sep;130(3):e153-e157.

• 全文
• 摘要

28.  Blencowe H, Cousens S, Mullany LC, et al. Clean birth and postnatal care practices to reduce neonatal deaths from sepsis and tetanus: a systematic review and Delphi estimation of mortality effect. BMC Public Health. 2011;11(suppl 3):S11.

• 全文
• 摘要

29.  Robinson CL, Romero JR, Kempe A, et al. Advisory Committee on Immunization Practices recommended immunization schedule for children and adolescents aged 18 years or younger - United States, 2018. MMWR Morb Mortal Wkly Rep. 2018 Feb 9;67(5):156-157.

• 全文
• 摘要

30.  Kim DK, Riley LE, Hunter P. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older - United States, 2018. MMWR Morb Mortal Wkly Rep. 2018 Feb 9;67(5):158-160.

• 全文
• 摘要

31.  Liang JL, Tiwari T, Moro P, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2018;67(No. RR-2):1–44.

• 全文
• 摘要

32.  Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Hamborsky J, Kroger A, Wolfe S, eds. 13th ed. Washington D.C. Public Health Foundation, 2015.

• 全文

33.  Public Health England. Tetanus immunoglobulin: recommendations on treatment and prophylaxis. April 2018 [internet publication].

• 全文

34.  Schon F, O'Dowd L, White J, et al. Tetanus: delay in diagnosis in England and Wales. J Neurol Neurosurg Psychiatry. 1994;57:1006-1007.

• 全文
• 摘要

35.  Public Health England. Tetanus: information for health professionals. March 2013 [internet publication].

• 全文

36.  Crone NE, Reder AT. Severe tetanus in immunized patients with high anti-tetanus titers. Neurology. 1992;42:761-764.

• 摘要

37.  Rushdy AA, White JM, Ramsay ME, et al. Tetanus in England and Wales, 1984-2000. Epidemiol Infect. 2003;130:71-77.

• 摘要

38.  Wood D, Webster E, Martinez D, et al. Case report: survival after deliberate strychnine self-poisoning, with toxicokinetic data. Crit Care. 2002;6:456-459.

• 全文
• 摘要

39.  Nakajima M, Aso S, Matsui H, et al. Clinical features and outcomes of tetanus: Analysis using a National Inpatient Database in Japan. J Crit Care. 2018 Apr;44:388-391.

• 摘要

40.  Campbell JI, Lam TM, Huynh TL, et al. Microbiologic characterization and antimicrobial susceptibility of Clostridium tetani isolated from wounds of patients with clinically diagnosed tetanus. Am J Trop Med Hyg. 2009;80:827-831.

• 全文
• 摘要

41.  Ahmadsyah I, Salim A. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. Br Med J (Clin Res Ed). 1985;291:648-650.

• 全文
• 摘要

42.  Yen LM, Dao LM, Day NPJ, et al. Management of tetanus: a comparison of penicillin and metronidazole. Paper presented at: Symposium of antimicrobial resistance in southern Viet Nam; 1997; Ho Chi Minh City, Vietnam.

43.  Kapoor W, Carey P, Karpf M. Induction of lactic acidosis with intravenous diazepam in a patient with tetanus. Arch Intern Med. 1981;141:944-945.

• 摘要

44.  Attygalle D, Rodrigo N. New trends in the management of tetanus. Expert Rev Anti Infect Ther. 2004;2:73-84.

• 摘要

45.  Gyasi HK, Fahr J, Kurian E, et al. Midazolam for prolonged intravenous sedation in patients with tetanus. Middle East J Anesthesiol. 1993;12:135-141.

• 摘要

46.  Okoromah CN, Lesi FE. Diazepam for treating tetanus. Cochrane Database Syst Rev. 2004;(1):CD003954.

• 摘要

47.  Buchanan N, Cane RD, Wolfson G, et al. Autonomic dysfunction in tetanus: the effects of a variety of therapeutic agents, with special reference to morphine. Intensive Care Med. 1979;5:65-68.

• 摘要

48.  Engrand N, Vilain G, Rouamba A, et al. Value of intrathecal baclofen in the treatment of severe tetanus in the tropical milieu. Med Trop (Mars). 2000;60:385-388. [In French]

• 摘要

49.  Saissy JM, Demaziere J, Vitris M, et al. Treatment of severe tetanus by intrathecal injections of baclofen without artificial ventilation. Intensive Care Med. 1992;18:241-244.

• 摘要

50.  Boots RJ, Lipman J, O'Callaghan J, et al. The treatment of tetanus with intrathecal baclofen. Anaesth Intensive Care. 2000;28:438-442.

• 摘要

51.  Dressnandt J, Konstanzer A, Weinzierl FX, et al. Intrathecal baclofen in tetanus: four cases and a review of reported cases. Intensive Care Med. 1997;23:896-902.

• 摘要

52.  Santos ML, Mota-Miranda A, Alves-Pereira A, et al. Intrathecal baclofen for the treatment of tetanus. Clin Infect Dis. 2004;38:321-328.

• 全文
• 摘要

53.  Lee C, Zhang X, Kwan WF. Electromyographic and mechanomyographic characteristics of neuromuscular block by magnesium sulphate in the pig. Br J Anaesth. 1996;76:278-283.

• 全文
• 摘要

54.  James MFM, Manson EDM. The use of magnesium sulphate infusions in the management of very severe tetanus. Intensive Care Med. 1985;11:5-12.

• 摘要

55.  Lipman J, James MFM, Erskine J, et al. Autonomic dysfunction in severe tetanus: magnesium sulfate as an adjunct to deep sedation. Crit Care Med. 1987;15:987-988.

• 摘要

56.  Attygalle D, Rodrigo N. Magnesium sulphate for control of spasms in severe tetanus. Can we avoid sedation and artificial ventilation? Anaesthesia. 1997;52:956-962.

• 摘要

57.  Thwaites CL, Yen LM, Loan HT, et al. Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial. Lancet. 2006;368:1436-1443.

• 摘要

58.  Attygalle D, Rodrigo N. Magnesium as first line therapy in the management of tetanus: a prospective study of 40 patients. Anaesthesia. 2002;57:811-817.

• 摘要

59.  Rodrigo C, Samarakoon L, Fernando SD, et al. A meta-analysis of magnesium for tetanus. Anaesthesia. 2012;67:1370-1374.

• 摘要

60.  Rocke DA, Wesley AG, Pather M, et al. Morphine in tetanus--the management of sympathetic nervous system overactivity. S Afr Med J. 1986;70:666-668.

• 摘要

61.  Buchanan N, Smit L, Cane RD, et al. Sympathetic overactivity in tetanus: fatality associated with propranolol. Br Med J. 1978;2:254-255.

• 全文
• 摘要

62.  Dolar D. The use of continuous atropine infusion in the management of tetanus. Intensive Care Med. 1992;18:26-31.

• 摘要

63.  Sutton DN, Tremlett MR, Woodcock TE, et al. Management of autonomic dysfunction in severe tetanus: the use of magnesium sulphate and clonidine. Intensive Care Med. 1990;16:75-80.

• 摘要

64.  Gregorakos L, Kerezoudi E, Dimopoulos G, et al. Management of blood pressure instability in severe tetanus: the use of clonidine. Intensive Care Med. 1997;23:893-895.

• 摘要

65.  Southorn PA, Blaise GA. Treatment of tetanus-induced autonomic nervous system dysfunction with continuous epidural blockade. Crit Care Med. 1986;14:251-252.

• 摘要

66.  Shibuya M, Sugimoto H, Sugimoto T, et al. The use of continuous spinal anesthesia in severe tetanus with autonomic disturbance. J Trauma. 1989;29:1423-1429.

• 摘要

67.  Freshwater-Turner D, Udy A, Lipman J, et al. Autonomic dysfunction in tetanus - what lessons can be learnt with special reference to alpha-2 agonists? Anaesthesia. 2007;62:1066-1070.

• 摘要

68.  Wesley AG, Hariparsad D, Pather M, et al. Labetalol in tetanus. The treatment of sympathetic nervous system overactivity. Anaesthesia. 1983;38:243-249.

• 摘要

69.  King WW, Cave DR. Use of esmolol to control autonomic instability of tetanus. Am J Med. 1991;91:425-428.

• 摘要

70.  Beards SC, Lipman J, Bothma PA, et al. Esmolol in a case of severe tetanus. Adequate haemodynamic control achieved despite markedly elevated catecholamine levels. S Afr J Surg. 1994;32:33-35.

• 摘要

71.  Hassel B. Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms. Toxins (Basel). 2013;5:73-83.

• 全文
• 摘要

72.  Thwaites CL, Yen LM, Glover C, et al. Predicting the clinical outcome of tetanus: the tetanus severity score. Trop Med Int Health. 2006;11:279-287.

• 全文
• 摘要

73.  Phillips LA. A classification of tetanus. Lancet. 1967;1i:1216-1217.

• 摘要

74.  Vakil BJ. Table ronde: propositions pour une classification internationale. In: 4th International Conference on Tetanus, vol 1. Dakar, Senegal: Fondation Merieux; 1975:3349-3367.

75.  Gurses N, Aydin M. Factors affecting prognosis of neonatal tetanus. Scan J Infect Dis. 1993;25:353-355.

• 摘要

76.  Davies-Adetugbo AA, Torimiro SE, Ako-Nai KA. Prognostic factors in neonatal tetanus. Trop Med Int Health. 1998;3:9-13.

• 全文
• 摘要

77.  Basu S, Paul DK, Ganguly S, et al. Risk factors for mortality from neonatal tetanus: 7 years experience in North Bengal, India. Ann Trop Paediatr. 2006;26:233-239.

• 摘要

78.  Lam PK, Trieu HT, Lubis IN, et al. Prognosis of neonatal tetanus in the modern management era: an observational study in 107 Vietnamese infants. Int J Infect Dis. 2015;33:7-11.

• 全文
• 摘要

79.  Loan HT, Parry J, Nga NT, et al. Semi-recumbent body position fails to prevent healthcare-associated pneumonia in Vietnamese patients with severe tetanus. Trans R Soc Trop Med Hyg. 2012;106:90-97.

• 全文
• 摘要

80.  Chalya PL, Mabula JB, Dass RM, et al. Ten-year experiences with tetanus at a tertiary hospital in northwestern Tanzania: a retrospective review of 102 cases. World J Emerg Surg. 2011;6:20.

• 全文
• 摘要

81.  Teknetzi P, Manios S, Katsouyanopoulos V. Neonatal tetanus--long-term residual handicaps. Arch Dis Child. 1983;58:68-69.

• 全文
• 摘要

82.  Anlar B, Yalaz K, Dizmen R. Long-term prognosis after neonatal tetanus. Dev Med Child Neurol. 1989;31:76-80.

• 摘要

83.  Barlow JL, Mung'Ala-Odera V, Gona J, et al. Brain damage after neonatal tetanus in a rural Kenyan hospital. Trop Med Int Health. 2001;6:305-308.

• 全文
• 摘要